Un abonnement à JoVE est nécessaire pour voir ce contenu. Connectez-vous ou commencez votre essai gratuit.
1Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry,University Hospital Tübingen, 2Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich,University Tübingen, 3German Center for Diabetes Research (DZD),University Tübingen
Chapitres
- 00:04Titre
- 00:54Inducing Experimental Nephrotic Syndrome with Doxorubicin
- 02:24Implantation of Sustained-Release Pellets Containing Aprotinin
- 04:01Assessing Urine Serine Protease Activity
- 05:32Results: Analysis of Doxorubicin-induced Nephrotic Syndrome
- 06:48Conclusion
Burada, 129S1/SvImJ farelerde deneysel Nefrotik sendromda indüksiyon doksorubisin hızlı retrobulbar enjeksiyonu ile açıklayın. Ayrıca Nefrotik fareler sürekli yayın granül içeren aprotinin idrar serin proteaz aktivitesi inhibe ve sodyum saklama önlemek için tedavi ediyoruz.
